Literature DB >> 34142343

Uterine Fibroids and Pregnancy: How Do They Affect Each Other?

Larissa M Coutinho1,2, Wiviane A Assis2, Ananda Spagnuolo-Souza2, Fernando M Reis3,4.   

Abstract

The present narrative review is aimed to rekindle discussion regarding whether and how uterine leiomyoma and pregnancy may impact each other. Although fibroids are hormone-dependent lesions, their growth during pregnancy seems to have a nonlinear trend. Besides placental estrogens and progesterone, an array of endocrine and paracrine factors affect fibroid blood supply, growth rate, and risk of degeneration along the gestational and puerperal periods. According to current evidence, the presence of leiomyomas might increase the risk of some adverse pregnancy outcomes. Although a causative relation between fibroids and spontaneous abortion is questionable, the presence of multiple submucosal lesions in certain populations, such as infertile women, may increase the risk of pregnancy loss. Slightly increased risks of placenta previa, placental abruption and fetal malpresentation may occur, mainly due to the mechanical influence of multiple and large fibroids. Cesarean section and preterm birth rates are also probably increased in the presence of fibroids. The risk associations are based on meta-analyses of cohort studies (level of evidence 2a), retrospective cohort studies (2b), case-control (3a), and cross-sectional studies (3b), but with a predominantly low risk of bias. For evaluating the growth pattern of leiomyomas and their real influence on obstetric outcomes, future studies should enroll women with fibroids diagnosed prior to pregnancy and follow them prospectively throughout the gestation and puerperium.
© 2021. Society for Reproductive Investigation.

Entities:  

Keywords:  Cesarean section; Fibroids; Miscarriage; Placenta previa; Placental abruption; Pregnancy; Pregnancy outcome; Uterine leiomyoma

Mesh:

Year:  2021        PMID: 34142343     DOI: 10.1007/s43032-021-00656-6

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   2.924


  48 in total

Review 1.  Uterine Fibroids - Current Trends and Strategies.

Authors:  Marcel Grube; Felix Neis; Sara Y Brucker; Stefan Kommoss; Jürgen Andress; Martin Weiss; Sascha Hoffmann; Florin-Andrei Taran; Bernhard Krämer
Journal:  Surg Technol Int       Date:  2019-05-15

Review 2.  Pregnancy outcome and uterine fibroids.

Authors:  Fabio Parazzini; Luca Tozzi; Stefano Bianchi
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-11-25       Impact factor: 5.237

3.  Uterine fibroid size modifications during pregnancy and puerperium: evidence from the first systematic review of literature.

Authors:  Amerigo Vitagliano; Marco Noventa; Attilio Di Spiezio Sardo; Gabriele Saccone; Salvatore Gizzo; Shara Borgato; Salvatore Giovannni Vitale; Antonio Simone Laganà; Giovanni Battista Nardelli; Pietro Salvatore Litta; Carlo Saccardi
Journal:  Arch Gynecol Obstet       Date:  2017-12-13       Impact factor: 2.344

Review 4.  Hormones and pathogenesis of uterine fibroids.

Authors:  Fernando M Reis; Enrrico Bloise; Tânia M Ortiga-Carvalho
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2015-11-25       Impact factor: 5.237

5.  Obstetric outcomes in women with sonographically identified uterine leiomyomata.

Authors:  G Iram Qidwai; Aaron B Caughey; Alison F Jacoby
Journal:  Obstet Gynecol       Date:  2006-02       Impact factor: 7.661

6.  High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.

Authors:  Donna Day Baird; David B Dunson; Michael C Hill; Deborah Cousins; Joel M Schectman
Journal:  Am J Obstet Gynecol       Date:  2003-01       Impact factor: 8.661

7.  Characterization of uterine leiomyomas by whole-genome sequencing.

Authors:  Miika Mehine; Eevi Kaasinen; Netta Mäkinen; Riku Katainen; Kati Kämpjärvi; Esa Pitkänen; Hanna-Riikka Heinonen; Ralf Bützow; Outi Kilpivaara; Anna Kuosmanen; Heikki Ristolainen; Massimiliano Gentile; Jari Sjöberg; Pia Vahteristo; Lauri A Aaltonen
Journal:  N Engl J Med       Date:  2013-06-05       Impact factor: 91.245

8.  Adverse obstetric outcomes in pregnant women with uterine fibroids in China: A multicenter survey involving 112,403 deliveries.

Authors:  Rong Zhao; Xin Wang; Liying Zou; Guanghui Li; Yi Chen; Changdong Li; Weiyuan Zhang
Journal:  PLoS One       Date:  2017-11-14       Impact factor: 3.240

9.  Relationship between a uterine fibroid diagnosis and the risk of adverse obstetrical outcomes: a cohort study.

Authors:  Kamilla Karlsen; Ulrik Schiøler Kesmodel; Ole Mogensen; Peter Humaidan; Pernille Ravn
Journal:  BMJ Open       Date:  2020-02-17       Impact factor: 2.692

10.  Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound-screening study.

Authors:  Shannon K Laughlin; Donna D Baird; David A Savitz; Amy H Herring; Katherine E Hartmann
Journal:  Obstet Gynecol       Date:  2009-03       Impact factor: 7.623

View more
  1 in total

1.  Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.

Authors:  Lisanne van Prooyen Schuurman; Erik A Sistermans; Diane Van Opstal; Lidewij Henneman; Mireille N Bekker; Caroline J Bax; Mijntje J Pieters; Katelijne Bouman; Sonja de Munnik; Nicolette S den Hollander; Karin E M Diderich; Brigitte H W Faas; Ilse Feenstra; Attie T J I Go; Mariëtte J V Hoffer; Marieke Joosten; Fenne L Komdeur; Klaske D Lichtenbelt; Maria P Lombardi; Marike G Polak; Fernanda S Jehee; Heleen Schuring-Blom; Servi J C Stevens; Malgorzata I Srebniak; Ron F Suijkerbuijk; Gita M Tan-Sindhunata; Karuna R M van der Meij; Merel C van Maarle; Vivian Vernimmen; Shama L van Zelderen-Bhola; Nicolien T van Ravesteyn; Maarten F C M Knapen; Merryn V E Macville; Robert-Jan H Galjaard
Journal:  Am J Hum Genet       Date:  2022-06-02       Impact factor: 11.043

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.